Moonwalk Biosciences

Miami, Florida, United States moonwalk.bio

Overview

Moonwalk Biosciences is a biotechnology company specializing in precision epigenetic medicines, aiming to reprogram cells to their healthy state by targeting the epigenetic code. Co-founded by Alex Aravanis, M.D., Ph.D., and Feng Zhang, Ph.D., the company has developed a novel platform technology providing a comprehensive view of the epigenome in health and disease.

Therapeutic areas

Cardiometabolic DiseasesLiver DiseasesObesity

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Moonwalk Biosciences in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

89bio, Inc.
United States
Akero Therapeutics, Inc.
United States
Alnylam Pharmaceuticals, Inc.
United States
Durect Corporation
USA
Gastro Innovations Incorporated
USA
Gastroenterology Research Foundation
United States
Gilead Sciences, Inc.
United States
Helicore Biopharma, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo